Active surveillance for prostate cancer: is it too active?

Behfar Ehdaie^{1

2}

Affiliations

¹ Department of Surgery, Urology Service, Center of Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Department of Epidemiology and Biostatistics, Center of Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Editorial

Behfar Ehdaie. BJU Int. 2016 Sep.

. 2016 Sep;118(3):343.

doi: 10.1111/bju.13473.

Behfar Ehdaie^{1

2}

¹ Department of Surgery, Urology Service, Center of Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Department of Epidemiology and Biostatistics, Center of Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

No abstract available

Comment on

Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study.
Bokhorst LP, Lepistö I, Kakehi Y, Bangma CH, Pickles T, Valdagni R, Alberts AR, Semjonow A, Strölin P, Montesino MF, Berge V, Roobol MJ, Rannikko A. Bokhorst LP, et al. BJU Int. 2016 Sep;118(3):366-71. doi: 10.1111/bju.13410. Epub 2016 Feb 12. BJU Int. 2016. PMID: 26765682